Kahira Pharmaceuticals & Chemical Industries Company (EGX: CPCI)

Market Cap	1.26B
Revenue (ttm)	1.38B
Net Income (ttm)	236.11M
Shares Out	14.93M
EPS (ttm)	15.81
PE Ratio	5.32
Forward PE	n/a
Dividend	5.00 (5.92%)
Ex-Dividend Date	n/a

Volume	21,846
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	37.70 - 88.55
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 15, 2024

About CPCI

Kahira Pharmaceuticals & Chemical Industries Company engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt. The company is involved in the provision of chemicals, extracts, veterinary medicines, and pesticides; and packaging and distribution activities. It also exports its products to Iraq, Yemen, Sudan, Somalia, Jordan, Libya, Senegal, Zimbabwe, South Sudan, Mali, and Kenya. Kahira Pharmaceuticals & Chemical Industries Company was founded in 1962 and is headquartered in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 2,032
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: CPCI

Financial Performance

In 2023, CPCI's revenue was 1.01 billion, a decrease of -9.61% compared to the previous year's 1.11 billion. Earnings were 97.09 million, a decrease of -41.42%.